PERCUTANEOUS ENDOSCOPIC ELECTRORESECTION OF RENAL PELVIC TUMORS
https://doi.org/10.17650/1726-9776-2011-7-1-85-89
Abstract
The paper gives the results of percutaneous electroresection of the renal pelvic wall with a tumor in 4 patients. The operation has been made for absolute indications: 3 patients had a single kidney and the fourth patient had a single functioning left kidney (the right pelvic dystopic kidney failed to function). In all the patients, the primary symptom of the disease was macrohematuria, the examination for which revealed a renal pelvic tumor measuring 1.2 to 2.5 cm in size. There were no complications after percutaneous electroresection of the renal pelvic wall with a tumor. Intrarenal BCG therapy was performed in the postoperative period. Percutaneous electroresection is indicated for tumors of the renal pelvis and the upper third of the ureter of the single kidney.
About the Authors
B. K. Komyakov
Department of Urology, I.I. Mechnikov Saint Petersburg State Medical Academy
Russian Federation
Russian Federation
B. G. Guliev
Department of Urology, I.I. Mechnikov Saint Petersburg State Medical Academy
Russian Federation
Russian Federation
A. I. Makovskiy
Department of Urology, I.I. Mechnikov Saint Petersburg State Medical Academy
Russian Federation
Russian Federation
V. E. Kim
Department of Urology, I.I. Mechnikov Saint Petersburg State Medical Academy
Russian Federation
Russian Federation
Sh. N. Idrisov
Department of Urology, I.I. Mechnikov Saint Petersburg State Medical Academy
Russian Federation
Russian Federation
References
1. Hall M.C., Womack S., Sagalowsky A.I. et al. Prognostic factors, recurrence and survival in transitional cell carcinoma of upper urinary tract: a 30-year experience in 252 patients. Urology 1998;52:594–601.
2. Jemal A., Siegel R., Ward E., Murray T. et al. Cancer statistics, 2007. Cancer J Clin 2007;57:43–66.
3. Комяков Б.К., Идрисов Ш.Н., Новиков А.И. и др. Оперативное лечение эпителиальных опухолей верхних мочевыводящих путей. Урология 2004;4:12–6.
4. Oosterlink W., Solsona E., Van der Meijden A.P. et al. EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma. Eur Urol 2004;46:147–54.
5. Argyropoulos A.N., Tolley D.A. Upper urinary tract transitional cell carcinoma: current treatment overview of minimally invasive approach. BJU Int 2007;99:982–7.
6. Zigeuner R., Pummer K. Urothelial carcinoma of the upper urinary tract: Surgical approach and prognostic factors. Eur Urol 2008;53:720–31.
7. Лопаткин Н.А., Мартов А.Г., Ергаков Д.В. Эндоскопические методы диагностики и лечения папиллярных опухолей верхних мочевыводящих путей. Урология 2001;36:46–51.
8. Shalhav A.L., Portis A.J., Mc Dougall E.M. et al. Laparoscopic nephroureterectomy. A new standard for the surgical management of upper tract transitional cell cancer. Urol Clin North Am 2000;27:761–73.
9. Simone G., Papalia R., Guaglianone S., Ferriero M. et al. Laparoscopic versus open nephroureterectomy: perioperative and oncologic outcomes from a randomized prospective study. Eur Urol 2009;56:520–6.
10. Roupret M., Traxer O., Tligui M. et al. Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection. Eur Urol 2007;51:709–14.
11. Irwin B.H., Berger A.K., Brandina R. et al. Complex percutaneous resections of upper tract urothelial carcinoma. J Endourol 2010;24:367–70.
12. Elliott D.S., Segura J.W., Lighter D. et al. Is nephoureterectomy necessary in all cases of upper tract transitional cell carcinoma? Long-term results of conservative endourologic management of upper tract transitional cell carcinoma in individuals with a normal contralateral kidney. Urology 2001;58:174–8.
13. Goel M.C., Mahendra V., Roperts J.G. Percutaneous management of renal pelvic urothelial tumors: long-term followup. J Urol 2003;169:925–9.
14. Soderdahl D.W., Fabrizio M.D., Rahman N.U. et al. Endoscopic treatment of upper tract transitional cell carcinoma. Urol Oncol 2005;23:114–22.
15. Clark P.E., Streem S.B., Geisinger M.A. 13-year experience with percutaneous management of upper tract transitional cell carcinoma. J Urol 1999;161:772–6.
16. Rastinehad A.R., Ost M.C., VanderBrink B.A. et al. A 20-year experience with percutaneous resection of upper tract transitional carcinoma: Is there an oncologic benefit with adjuvant bacillus Calmette-Guerin therapy? Urology 2009;73:27–31.
17. Yamada Y., Kobayashi Y., Yao A. et al. Nephrostomy tract tumor sedding following percutaneous manipulation of a renal pelvic carcinoma. Acta Urol Japan 2002;48:415–8.
18. Schenberg M.P., Van Arsdalen K.N., Wein A.J. The management of transitional cell carcinoma in solitary renal units. J Urol 1991;146:700–3.
19. Plancke H.R., Strijbos W.E., Delaere K.P. Percutaneous endoscopic treatment of urothelial tumors of the renal pelvis. Br J Urol 1995;75:736–9.
20. Patel A., Soonawalla P., Shepherd S.F. et al. Long-term outcome after percutaneous treatment of transitional cell carcinoma of the renal pelvis. J Urol 1996;155:868–74.
21. Palou J., Piovesan L.F., Huguet J. et al. Percutaneous nephroscopic management of upper urinary tract transitional cell carcinoma: Recurrence and long-term follow up. J Urol 2004;172:66–9.
Review
For citations:
Komyakov B.K., Guliev B.G., Makovskiy A.I., Kim V.E., Idrisov Sh.N. PERCUTANEOUS ENDOSCOPIC ELECTRORESECTION OF RENAL PELVIC TUMORS. Cancer Urology. 2011;7(1):85-89. (In Russ.) https://doi.org/10.17650/1726-9776-2011-7-1-85-89
Views:
664
Email this article 